Skip to main content
Login
Contact
Subscribe
Search form
Search
Custer County Chief
Home
Forms
News
Sports
Classifieds
Place a Classified Ad
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
Callaway, NE
Chamber of Commerce
Community of Arnold
Custer County Courthouse
Custer County Foundation
Custer Economic Development Corp.
Police Department
Arcadia Schools
Arnold Schools
Broken Bow Schools
Callaway Schools
City of Broken Bow
Loup Schools
Mullen Schools
Sandhill Schools
Sargent Schools
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Moleculin Biotech CS
(NQ:
MBRX
)
1.140
USD
-0.020 (-1.72%)
Official Closing Price
/ Updated:
7:58 PM EDT, Jun 2, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
2,102,700
Open
1.200
Bid (Size)
1.080 (17)
Ask (Size)
1.140 (25)
Prev. Close
1.160
Today's Range
1.080 - 1.220
52wk Range
0.3200 - 1.970
Shares Outstanding
25,768,861
Dividend Yield
N/A
Performance
YTD
+23.87%
+23.87%
1 Month
+5.56%
+5.56%
3 Month
+70.15%
+70.15%
6 Month
+10.68%
+10.68%
1 Year
-5.00%
-5.00%
Top News
More News
Moleculin Announces Emory University Clinical Trial of WP1066 Begins Enrollment
June 02, 2020
Pediatric trial marks the second brain tumor trial of Moleculin's lead STAT3 inhibitor
Read More
from
PR Newswire
Moleculin Announces Common Stock Will Resume Trading on the NASDAQ on May 28, 2020
May 27, 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses,...
Read More
from
PR Newswire
More News
Read More
Nasdaq Scheduled Resumption in Moleculin Biotech, Inc.
May 27, 2020
from
GlobeNewswire News Releases
Moleculin Provides Update on Coronavirus Drug Development
May 27, 2020
from
PR Newswire
Nasdaq Halts Moleculin Biotech Inc.
May 18, 2020
from
GlobeNewswire News Releases
Moleculin Announces Nasdaq Trading Halt Pending Receipt of Additional Information
May 18, 2020
from
PR Newswire
Moleculin Provides Additional Comments Regarding Trading Halt
May 11, 2020
from
PR Newswire
Investor Alert: Kaplan Fox Investigates Moleculin Biotech, Inc.
May 08, 2020
from
PR Newswire
Moleculin Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 15, 2020
May 08, 2020
from
PR Newswire
Moleculin Announces Trading Halt
May 04, 2020
from
PR Newswire
Moleculin to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference
April 29, 2020
from
PR Newswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
